ArticleOncogene2017

Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p.

E G Seviour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.